UID:
almafu_9959328944302883
Umfang:
1 online resource
Ausgabe:
Second edition.
ISBN:
9781118408520
,
1118408527
,
1118408535
,
9781118408506
,
1118408500
,
9781118408537
Anmerkung:
Preceded by Handbook of dermatology / Margaret W. Mann ... [et al.]. 2009.
,
〈P〉Preface xv〈/p〉 〈p〉Acknowledgments xvii〈/p〉 〈p〉〈b〉Part 1 General Dermatology 1〈/b〉〈/p〉 〈p〉〈b〉Common Work-Ups, Signs, and Management 3〈/b〉〈/p〉 〈p〉Dermatologic Differential Algorithm 3〈/p〉 〈p〉Direct Immunofluorescence (Dif) 3〈/p〉 〈p〉False positive/negative DIFs 3〈/p〉 〈p〉Workup Quick Reference Orders 4〈/p〉 〈p〉Acne 6〈/p〉 〈p〉Alopecia Workup 7〈/p〉 〈p〉Telogen effluvium 10〈/p〉 〈p〉Androgenic alopecia 10〈/p〉 〈p〉Alopecia areata 11〈/p〉 〈p〉Other alopecia treatments 12〈/p〉 〈p〉Aphthosis Workup and Treatment 13〈/p〉 〈p〉Dermatologic Signs 15〈/p〉 〈p〉Folliculitis 21〈/p〉 〈p〉Melasma 22〈/p〉 〈p〉〈b〉Immunology and Immunologic Disease 24〈/b〉〈/p〉 〈p〉Lupus Erythematosus 24〈/p〉 〈p〉Autoantibody 26〈/p〉 〈p〉Sensitivities and specificities 26〈/p〉 〈p〉In connective tissue diseases 28〈/p〉 〈p〉Anti-nuclear antibodies 29〈/p〉 〈p〉ANCA (Anti-neutrophil cytoplasmic antibodies) 30〈/p〉 〈p〉Treatment of ANCA-associated vasculitis 30〈/p〉 〈p〉Vasculitis 31〈/p〉 〈p〉Small vessel vasculitis 31〈/p〉 〈p〉Medium vessel vasculitis 33〈/p〉 〈p〉Large vessel vasculitis 34〈/p〉 〈p〉Cryoglobulinemia 34〈/p〉 〈p〉Bullous Disorders 36〈/p〉 〈p〉Intracorneal/subcorneal 36〈/p〉 〈p〉Intraepidermal 36〈/p〉 〈p〉Suprabasilar 37〈/p〉 〈p〉Subepidermal with little inflammation 37〈/p〉 〈p〉Epidermolysis bullosa 39〈/p〉 〈p〉Major bullous diseases -- clinicopathologic findings 42〈/p〉 〈p〉Complement 46〈/p〉 〈p〉Angioedema and complement levels 46〈/p〉 〈p〉Complement deficiencies 47〈/p〉 〈p〉GVHD 47〈/p〉 〈p〉HLA associations 48〈/p〉 〈p〉Th profiles 50〈/p〉 〈p〉〈b〉Special Sites: Glands, Nail, Bone, Mucosa 51〈/b〉〈/p〉 〈p〉Glands 51〈/p〉 〈p〉Nail terminology 53〈/p〉 〈p〉Disorders or drugs associated with nail, Bone, or ocular findings 57〈/p〉 〈p〉Genital ulcers 67〈/p〉 〈p〉〈b〉Infection and Infestations 68〈/b〉〈/p〉 〈p〉Fungal Disease / Mycoses 68〈/p〉 〈p〉Laboratory tests 68〈/p〉 〈p〉Superficial mycoses 68〈/p〉 〈p〉Cutaneous mycoses 69〈/p〉 〈p〉Subcutaneous mycoses 71〈/p〉 〈p〉Systemic mycoses 73〈/p〉 〈p〉Opportunistic mycoses 75〈/p〉 〈p〉Viruses and diseases 78〈/p〉 〈p〉Human papilloma virus 79〈/p〉 〈p〉Other viral diseases 80〈/p〉 〈p〉Infections/Bugs 83〈/p〉 〈p〉Vector-borne diseases 83〈/p〉 〈p〉Creatures in dermatology 88〈/p〉 〈p〉〈b〉Contact and Plant Dermatitis 93〈/b〉〈/p〉 〈p〉Patch testing 93〈/p〉 〈p〉Common contact allergens 95〈/p〉 〈p〉Allergic vs. irritant contact dermatitis 104〈/p〉 〈p〉Allergens -- location specific 105〈/p〉 〈p〉Features suggestive of specific irritant/toxin 106〈/p〉 〈p〉Plants and Dermatoses 106〈/p〉 〈p〉〈b〉Tumors and Infiltrates 109〈/b〉〈/p〉 〈p〉Cutaneous T Cell Lyphoma 109〈/p〉 〈p〉Cutaneous B-cell lymphoma 113〈/p〉 〈p〉Leukemia cutis 113〈/p〉 〈p〉Monoclonal Gammopathies in Dermatology 114〈/p〉 〈p〉Tumors and gene associations 115〈/p〉 〈p〉〈i〉For Melanoma, BCC, and SCC, see Skin Cancer〈/i〉 221〈/p〉 〈p〉〈b〉Systemic and Metabolic Diseases 117〈/b〉〈/p〉 〈p〉Amyloidoses 117〈/p〉 〈p〉Histiocytosis 119〈/p〉 〈p〉Xanthomas 124〈/p〉 〈p〉Hyperlipoproteinemias 125〈/p〉 〈p〉Vitamin Deficiencies/Hypervitaminoses 127〈/p〉 〈p〉〈b〉Pediatric and Pregnancy Dermatology 131〈/b〉〈/p〉 〈p〉Vascular tumors and malformation 131〈/p〉 〈p〉Infantile Hemangioma (IH) Management 132〈/p〉 〈p〉Neonatal vesiculopustular eruptions 137〈/p〉 〈p〉Genodermatoses 142〈/p〉 〈p〉Chromosome abnormalities 171〈/p〉 〈p〉Disorders of cornification 171〈/p〉 〈p〉Disorders of connective tissue 175〈/p〉 〈p〉Ehlers-Danlos 177〈/p〉 〈p〉Collagen types 178〈/p〉 〈p〉Disorder of hair, Nail, ectoderm 179〈/p〉 〈p〉Tumor syndromes 185〈/p〉 〈p〉Disorders of vascularization 186〈/p〉 〈p〉Disorders of metabolism 189〈/p〉 〈p〉Porphyrias 191〈/p〉 〈p〉Disorders of pigmentation 193〈/p〉 〈p〉Immunodeficiency syndromes 196〈/p〉 〈p〉Miscellaneous 198〈/p〉 〈p〉Dermatoses of pregnancy 200〈/p〉 〈p〉〈b〉Dermoscopy and Dermatopathology 202〈/b〉〈/p〉 〈p〉Dermoscopy 202〈/p〉 〈p〉Dermatopathology 206〈/p〉 〈p〉Histochemical staining 206〈/p〉 〈p〉Immunohistochemical staining 207〈/p〉 〈p〉Pathologic bodies 210〈/p〉 〈p〉Cysts 214〈/p〉 〈p〉Other derm path buzzwords, Patterns, DDx 215〈/p〉 〈p〉〈b〉Part 2 Surgical and Cosmetic Dermatology 219〈/b〉〈/p〉 〈p〉〈b〉Surgical Dermatology 221〈/b〉〈/p〉 〈p〉Skin cancer 221〈/p〉 〈p〉Surgical margin guidelines 221〈/p〉 〈p〉Indication for Mohs micrographic surgery 222〈/p〉 〈p〉Melanoma 223〈/p〉 〈p〉Squamous cell carcinoma (SCC) 228〈/p〉 〈p〉Prophylactic antibiotics and antivirals 230〈/p〉 〈p〉Guideline for Prophylactic antibiotics 230〈/p〉 〈p〉Algorithm for antibiotic prophylaxis 231〈/p〉 〈p〉Guideline for prophylactic antivirals 231〈/p〉 〈p〉Antiseptic scrubs 232〈/p〉 〈p〉Anesthetics 234〈/p〉 〈p〉Dose calculation 234〈/p〉 〈p〉Standard formula for buffered Lidocaine 234〈/p〉 〈p〉Tumescent anesthesia 234〈/p〉 〈p〉Topical anesthetic (see drug section pg. 316) 235〈/p〉 〈p〉Adverse reaction to local anesthetics 235〈/p〉 〈p〉Local anesthetic 236〈/p〉 〈p〉Nerve blocks 237〈/p〉 〈p〉Surgical anatomy 237〈/p〉 〈p〉Anatomy of the face 237〈/p〉 〈p〉Danger zones in surgery 242〈/p〉 〈p〉Dermatomal distribution of sensory nerves 244〈/p〉 〈p〉Anatomy of the lower extremity venous system 245〈/p〉 〈p〉Anatomy of the nail 246〈/p〉 〈p〉Cutaneous reconstruction 247〈/p〉 〈p〉Undermining depths in reconstruction 248〈/p〉 〈p〉Reconstruction algorithm: STAIRS 248〈/p〉 〈p〉Sutures 260〈/p〉 〈p〉Absorbable 260〈/p〉 〈p〉Nonabsorbable 261〈/p〉 〈p〉Suture removal time 262〈/p〉 〈p〉Electrosurgery 262〈/p〉 〈p〉Wound healing 262〈/p〉 〈p〉Wound dressing 263〈/p〉 〈p〉〈b〉Cosmetic Dermatology 264〈/b〉〈/p〉 〈p〉Laser 264〈/p〉 〈p〉Laser fundamentals 264〈/p〉 〈p〉Laser treatment of tattoo pigment 266〈/p〉 〈p〉Photoinduced eye injury 267〈/p〉 〈p〉Laser wavelength depth of penetration and the electromagnetic spectrum 268〈/p〉 〈p〉Absorption spectra of major skin chromophores 268〈/p〉 〈p〉Photodynamic therapy 269〈/p〉 〈p〉Photosensitizer properties and options 269〈/p〉 〈p〉PDT Protocol 270〈/p〉 〈p〉UV spectrum 271〈/p〉 〈p〉UV spectrum and wavelengths 271〈/p〉 〈p〉UVB protection vs SPF 272〈/p〉 〈p〉UV protection measurements 272〈/p〉 〈p〉UV associations/specificities 273〈/p〉 〈p〉Glogau wrinkle scale 273〈/p〉 〈p〉Fitzpatrick skin type 274〈/p〉 〈p〉Chemical peels 274〈/p〉 〈p〉Pre-peel consideration 274〈/p〉 〈p〉Peeling agents 275〈/p〉 〈p〉Botulinum toxin 277〈/p〉 〈p〉Injectable for adipolysis 280〈/p〉 〈p〉Fillers 281〈/p〉 〈p〉Protocol for vascular occlusion from fillers 288〈/p〉 〈p〉Venous disease treatment 288〈/p〉 〈p〉Vein treatment algorithm 288〈/p〉 〈p〉Sclerotherapy 289〈/p〉 〈p〉Preparing dilution of sclerosants 290〈/p〉 〈p〉CEAP classification for venous disease 292〈/p〉 〈p〉Venous clinical severity score 292〈/p〉 〈p〉〈b〉Part 3 Drugs and Therapies 293〈/b〉〈/p〉 〈p〉Medication Quick Reference 295〈/p〉 〈p〉Topical steroids classified by strength 295〈/p〉 〈p〉Nonsteroidals 297〈/p〉 〈p〉Commonly used drugs in dermatology 297〈/p〉 〈p〉Systemic Medications 302〈/p〉 〈p〉Antimalarials 302〈/p〉 〈p〉Immunosuppressive agents 303〈/p〉 〈p〉Systemic retinoids 306〈/p〉 〈p〉Biologics 307〈/p〉 〈p〉General Reference 310〈/p〉 〈p〉Metric measurements 310〈/p〉 〈p〉Dose calculations 310〈/p〉 〈p〉Topical medication dispensing and absorption 310〈/p〉 〈p〉Corticosteroid Dosage Equivalence 311〈/p〉 〈p〉Acne -- Topical 311〈/p〉 〈p〉Antibiotics/antimicrobial 311〈/p〉 〈p〉Keratolytics 312〈/p〉 〈p〉Retinoids 313〈/p〉 〈p〉Others 313〈/p〉 〈p〉Acne -- Oral 314〈/p〉 〈p〉Antibiotics 314〈/p〉 〈p〉Retinoids 315〈/p〉 〈p〉Others 315〈/p〉 〈p〉Analgesics 315〈/p〉 〈p〉Anesthetics -- topical (see also topical anesthetic pg. 235) 316〈/p〉 〈p〉Anesthetics -- topical compounded 316〈/p〉 〈p〉Antibiotics 316〈/p〉 〈p〉Topical/antiseptic 316〈/p〉 〈p〉Systemic 317〈/p〉 〈p〉Preoperative prophylaxis see pg. 230〈/p〉 〈p〉Post
Weitere Ausg.:
Print version: Mann, Margaret W., author. Handbook of dermatology Hoboken, NJ : Wiley Blackwell, 2019 ISBN 9781118408544
Sprache:
Englisch
Schlagwort(e):
Handbook.
;
Electronic books.
;
Handbook.
;
Handbook.
;
Electronic books.
URL:
https://onlinelibrary.wiley.com/doi/book/10.1002/9781118408506
URL:
https://onlinelibrary.wiley.com/doi/book/10.1002/9781118408506
URL:
https://onlinelibrary.wiley.com/doi/book/10.1002/9781118408506
